Products

  • Products
  • Service
  • Solutions

Cell Quality: The Core Guarantee for the Validity of MAT Pyrogen Detection

High-quality cell status enables more sensitive intracellular pathway transmission and broadens the detection applicability for different samples. Only when cell quality is guaranteed can the detection data be truly meaningful. How does PyroSup™ MAT Cell safeguard detection data from traceability to quality control?


01  Cell Traceability: The Basic Threshold of MAT

PyroSup™ MAT detection cells have obtained official commercial authorization from preservation institutions. The PyroSup™ Pyrogen Detection Kit (MAT Method) by Huzhou Shenke can fully meet compliance requirements and help address three core pain points in Monocyte Activation Test (MAT) detection (see Table 1).


Table 1:Application Scenarios and Declaration Feasibility of Monocyte Cell Lines in MAT Detection

Monocyte Cell LineEndotoxin Pyrogen FeasibilityNon-endotoxin Pyrogen FeasibilityDeclaration Feasibility
THP-1FailedFailedAllowed for declaration after authorization
MM-6SuccessfulSuccessfulRestricted cell line source compliance; data integrity may be challenged
HL-60SuccessfulSuccessfulAllowed for declaration after authorization
SCSuccessfulSuccessfulAllowed for declaration after authorization

Feel free to contact us for more details.


  • Scarce Compliant Cell Lines

Pharmacopoeias of various countries have set strict screening criteria for the functional characteristics and reaction stability of special monocytes for MAT, and cell lines meeting the basic requirements are very limited[1].

  • Insufficient Pyrogen Detection Efficiency

Pyrogens are divided into endotoxins and non-endotoxins. Most monocyte cell lines can only specifically identify endotoxins with poor detection capability for non-endotoxin pyrogens, posing a high risk of missed detection[2].

  • Mandatory Requirement for Inhibitor Testing

Consistent with the culture method, indicator cell culture method and nucleic acid method have all added inhibitor testing with specific protocols and test contents specified, aiming to eliminate the interference of product matrix on PCR reactions.

  • High Difficulty in Cell Traceability Compliance

Regulatory authorities explicitly require traceable sources of MAT cells. However, some commercially available cell lines lack a complete traceability chain, and globally recognized authoritative cell banks widely accepted by regulators (such as ATCC, ECACC, CCTCC, DSMZ, etc.) are limited in number[3].

 

Compliant cell traceability serves as the fundamental guarantee for PyroSup™ Pyrogen Detection Kit to meet declaration requirements. To further improve detection reproducibility and enhance declaration success rate, we have formulated more detailed cell production and quality control protocols based on extensive experimental data, exceeding the conventional requirements of national pharmacopoeias.


02 Stricter Standards: Passage and Quality Control of MAT Cells

To ensure the accuracy, stability and detection efficiency of MAT-based pyrogen detection, we have established a comprehensive full-dimensional production and quality control system for MAT cells—the core of detection—to control quality from the cellular source and guarantee the reliability of detection results.


  • Basic Cell Standards

MAT cells are strictly required to have uniform morphology, good growth status and no cell aggregation, with stable cell viability of ≥90%; otherwise, the cells will not be released for use (see Figure 1).


175849173244.jpg

Figure 1 :Microscopic images of monocyte cell lines (left: well-conditioned cells; right: unqualified cells)

 

  • Microbial Safety Testing

In the cell quality control release process, all MAT cells put into use undergo three special tests for mycoplasma, bacteria and fungi, with all results negative. The purity and viability of cells meet the standards for detection applications.

 

  • Performance Quality Control Requirements

The cells feature high recognition specificity and response sensitivity to pyrogens, as well as stable detection repeatability. The intra-batch and inter-batch deviation of quantitative detection is precisely controlled at ≤30%. They can stably trigger specific pyrogen response reactions and meet the accurate pyrogen detection needs of various samples.


Meanwhile, in the entire production process and practical detection application of MAT kits, we conduct regular, full-coverage and high-standard QC quality control testing, verifying multiple core indicators including linear range, limit of quantitation, blank well value, non-endotoxin pyrogen detection, and viable cell count verification. All quality control items must reach compliance standards.


We always adhere to the core principle of cell functional adaptation + full-dimensional quality control compliance. Through strict cell quality control, unqualified cells are prevented from being put into application, ensuring the product quality of MAT detection kits and ultimately improving the accuracy, stability and reliability of pyrogen detection results.


03 PyroSup™ Pyrogen Detection Kit (MAT Method)


Catalog No.: 1502100


  • Compliant Traceability Lays a Solid Foundation:The cells are commercially authorized with a clear and traceable chain, meeting declaration compliance requirements and avoiding risks from the source.

  • Multi-dimensional Optimization Expands Application Boundaries:Focusing on dual dimensions of cell performance optimization and sample preprocessing upgrading, we adopt a "special training strategy" to continuously break the limitations of detection scenarios and expand the scope of application.

  • Stable Quality Provides Strong Support:With comprehensive performance verification and dual certification by regulatory authorities and end customers, it delivers stable and reliable performance and ensures the consistency of detection results.

  • Practical Cases Demonstrate Professional StrengthIt: has successful declaration cases in the EU market, transforming laboratory scientific optimization into practical and feasible solutions.


References

[1] National Pharmacopoeia Commission of the People’s Republic of China (NPC). 2020. Pharmacopoeia of the People’s Republic of China: General Chapter 3301 Detection of Mycoplasma [online]. 11th ed. Beijing: China Medical Science Press. 

[2] U.S. Food and Drug Administration (FDA). 2023. 21 CFR Part 610: Biological products; general [online]. Silver Spring, MD: U.S. Food and Drug Administration.

[3] European Directorate for the Quality of Medicines & HealthCare (EDQM). 2022. European Pharmacopoeia: 2.6.8 Pyrogens [online]. 10th ed. Strasbourg: Council of Europe.